MONCTON, NB, Sept. 6, 2018 /CNW/ - Organigram Holdings Inc.
(TSX VENTURE:OGI) (OTCQX:OGRMF), the parent company of Organigram
Inc. (the "Company" or "Organigram"), a leading licensed producer
of medical marijuana, today announced that it has qualified to
trade on the OTCQX® Best Market.
Moving to the OTCQX® Best Market is a reflection of Organigram's
continued growth and investor interest in the United States and beyond. Organigram
stock will begin trading immediately under the ticker symbol
"OGRMF".
"Our industry has seen tremendous momentum in Canada and around the world, so it's natural
that the investment community is increasingly interested in
Organigram's approach, product portfolio and vision of the future,"
said Paolo De Luca, Chief Financial
Officer of Organigram. "The OTCQX® Best Market provides the
most prestigious trading market available by OTC Markets Group
reflecting Organigram's own commitment to excellence and
growth. We believe this move to be well-received by investors
and investment professionals alike."
Organigram has seen its U.S. trading volumes as a percentage of
its overall trading volumes increase substantially in 2018 and
believes that upgrading to the OTCQX® Best Market should help drive
increased cross-border liquidity. Since launching the Company's
strategy for adult recreational cannabis and securing distribution
across six Canadian provinces to date, De Luca states that the move
to OTCQX is the next step. "As interest in Organigram grows
outside of our national borders, the move to the OTCQX® Best Market
is a natural and welcome progression."
The OTCQX® Best Market is the U.S. market of choice for many
reputable and globally recognized companies including Adidas AG,
Roche Holding Ltd and Danone SA.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed
company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing the highest-quality,
indoor-grown cannabis for patients and adult recreational consumers
in Canada, as well as developing
international business partnerships to extend the company's global
footprint. In anticipation of the legal adult use recreational
cannabis in Canada, Organigram has
developed a portfolio of brands including The Edison Cannabis
Company, Ankr Organics and Trailer Park Buds. Organigram's primary
facility is located in Moncton, New
Brunswick and the Company is regulated by the Access to
Cannabis for Medical Purposes Regulations ("ACMPR").
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
This news release contains forward-looking information which
involves known and unknown risks, uncertainties and other factors
that may cause actual events to differ materially from current
expectations. Important factors - including the availability of
funds, consummation of definitive documentation, the results of
financing efforts, crop yields - that could cause actual results to
differ materially from the Company's expectations are disclosed in
the Company's documents filed from time to time on SEDAR (see
www.sedar.com). Readers are cautioned not to place undue reliance
on these forward-looking statements, which speak only as of the
date of this press release. The Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise.
SOURCE OrganiGram